P
ProLynx at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
ProLynx brings 3 presentations to ObesityWeek 2026 in National Harbor. Its program centres on making anti-obesity peptides last much longer without lipidation. It covers an ultralong-acting amylin agonist that sustains weight loss for 12 weeks in obese rats after a single dose.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
P ProLynx San Francisco, CA | |
Biotech using a linker platform to make ultralong-acting anti-obesity peptide therapeutics. | Poster Sat Nov 14 7:30pm–8:30pm Unlipidated Anti-Obesity Peptides Achieve Body Weight Reductions Similar to Those of Lipidated Counterparts Neuroscience of appetite and eatingObesity pharmacotherapy and drug development Poster Sat Nov 14 7:30pm–8:30pm Ultralong-Acting Amylin Agonist Elicits Sustained 12-Week Weight Loss in DIO Rats After Single Dose Obesity pharmacotherapy and drug developmentMetabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm A Platform for Ultralong-Acting Anti-Obesity Peptide Therapeutics Independent of Lipidation Neuroscience of appetite and eatingObesity pharmacotherapy and drug development |
Find decision makers at ProLynx
Tell us what you sell and we’ll find the people at ProLynx most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction